These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33 related articles for article (PubMed ID: 28570737)
21. A randomized, dose-escalation study of subconjunctival and intravitreal injections of sirolimus in patients with diabetic macular edema. Dugel PU; Blumenkranz MS; Haller JA; Williams GA; Solley WA; Kleinman DM; Naor J Ophthalmology; 2012 Jan; 119(1):124-31. PubMed ID: 22115710 [TBL] [Abstract][Full Text] [Related]
22. Comparison of intravitreal bevacizumab alone or combined with triamcinolone versus triamcinolone in diabetic macular edema: a randomized clinical trial. Lim JW; Lee HK; Shin MC Ophthalmologica; 2012; 227(2):100-6. PubMed ID: 21997197 [TBL] [Abstract][Full Text] [Related]
23. Intravitreal bevacizumab alone or combined with 1 mg triamcinolone in diabetic macular edema: a randomized clinical trial. Riazi-Esfahani M; Riazi-Esfahani H; Ahmadraji A; Karkhaneh R; Mahmoudi A; Roohipoor R; Ghasemi F; Yaseri M Int Ophthalmol; 2018 Apr; 38(2):585-598. PubMed ID: 28349504 [TBL] [Abstract][Full Text] [Related]
25. Subconjunctival Delivery of p75NTR Antagonists Reduces the Inflammatory, Vascular, and Neurodegenerative Pathologies of Diabetic Retinopathy. Galan A; Barcelona PF; Nedev H; Sarunic MV; Jian Y; Saragovi HU Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):2852-2862. PubMed ID: 28570737 [TBL] [Abstract][Full Text] [Related]
26. Comparative effectiveness of intravitreal bevacizumab with or without triamcinolone acetonide for treatment of diabetic macular edema. Jin E; Luo L; Bai Y; Zhao M Ann Pharmacother; 2015 Apr; 49(4):387-97. PubMed ID: 25622852 [TBL] [Abstract][Full Text] [Related]
27. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases]. Jonas JB; Kreissig I; Kamppeter B; Degenring RF Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306 [TBL] [Abstract][Full Text] [Related]